Market Access Law Impact Assessment is an analytical activity launched when a project or revision of the list of reimbursed drugs is being prepared in order to present the consequences of changing funding conditions of the drug or its competition.
The assessment enables a fast response and allows taking appropriate steps to reduce the adverse effects of the change for the Clients product.
Arcana Institute
